Upload
mariam-shipton
View
215
Download
2
Tags:
Embed Size (px)
Citation preview
• Mary Beth Busbyfounding board member of the Fragile X Research Foundation (FRAXA)
• Walter KaufmannDirector, Center for Genetic Disorders of Cognition and Behavior, Kennedy Krieger Institute, The Johns Hopkins University
• Karen UsdinChief, Gene Structure and Disease SectionLMCB, NIDDK
Understanding the molecular Understanding the molecular basis of the FMR1 gene basis of the FMR1 gene
disordersdisorders
Karen UsdinKaren Usdin
5’ UTR5’ UTR
exon 1exon 1 intron 1intron 1
(CGG)n(CGG)n
promotepromoterr
X chromosome
QuickTime™ and aTIFF (Uncompressed) decompressor
are needed to see this picture.
FXPOI FXPOI
male
female
The Repeat Expansion Diseases
Myotonic Myotonic dystrophdystroph
yytype 1type 1
Myotonic Myotonic dystrophdystroph
yytype 1type 1
Also: SCA 8, SCA12, and HDL2Also: SCA 8, SCA12, and HDL2Also: SCA 8, SCA12, and HDL2Also: SCA 8, SCA12, and HDL2
FMR1 FMR1 disordersdisorders
FMR1 FMR1 disordersdisorders
Friedreich Friedreich ataxiaataxia
Friedreich Friedreich ataxiaataxia
Haw River SyndromeHaw River Syndrome(DRPLA)(DRPLA)
Haw River SyndromeHaw River Syndrome(DRPLA)(DRPLA)
HuntingtoHuntington diseasen diseaseHuntingtoHuntington diseasen disease
SCA 1, 2, 6, 7SCA 1, 2, 6, 7SCA 1, 2, 6, 7SCA 1, 2, 6, 7
Kennedy DiseaseKennedy Disease(SBMA)(SBMA)
Kennedy DiseaseKennedy Disease(SBMA)(SBMA)
Progressive Progressive myoclonus myoclonus epilepsyepilepsy
Progressive Progressive myoclonus myoclonus epilepsyepilepsy
FRAXE MRFRAXE MRFRAXE MRFRAXE MR
SCA10SCA10SCA10SCA10 Myotonic Myotonic dystrophydystrophy
type 2type 2
Myotonic Myotonic dystrophydystrophy
type 2type 2
ORPromoter 5’ UTR ORF 3’ UTRIntron
(CGG)n (CTG)n(CAG)n(GAA)n (ATTCT)n(C4GC4GCG)n (CCTG)n
Premutation symptoms result from RNA “toxicity”
Premutation symptoms result from RNA “toxicity”
• The RNA is somehow deleterious
• the CGG-repeats may• trigger deleterious processes • sequester proteins that are
important for normal neuronal and ovarian function
QuickTime™ and a decompressor
are needed to see this picture.
QuickTime™ and a decompressor
are needed to see this picture.
RNA “toxicity” hypothesisRNA “toxicity” hypothesis
• The RNA is somehow deleterious
• the CGG-repeats may initiate or trigger deleterious processes
• the CGG-repeats may sequester proteins that are important for normal neuronal and ovarian function
Is FXTAS a laminopathy?Is FXTAS a laminopathy?
• mutations in Lamin A/C are associated with one form of Charcot-Marie-Tooth disease, a neurological disorder
• other mutations in Lamin A/C result in premature aging
•learning difficulties•macroorchidism•altered circadian rhythms•rapid early growth rate•audiogenic seizures•anxiety
QuickTime™ and aVC Coding
QuickTime™ and aVC Coding
QuickTime™ and aVC Coding
QuickTime™ and aVC Coding
Qin and Beebe-Smith (NIMH)
WT
KO
FMRP structureFMRP structure
QuickTime™ and aTIFF (Uncompressed) decompressor
are needed to see this picture.
NDF
RNAs bound by FMRPRNAs bound by FMRP
• FMR1• Glucocorticoid receptor• GABAA receptor subunits• CAMKIIα• MAP1B• Rac1• Calbindin• Vimentin• etc, etc
Increased rates of cerebral glucose metabolism in a mouse model of fragile X mental retardation
Increased rates of cerebral glucose metabolism in a mouse model of fragile X mental retardation
Qin, Kang, and Beebe Smith (2002) (NIMH)
WT
KO
Nissl staining [14C] DG
Results of “fishing” for FMRP interacting proteins
Results of “fishing” for FMRP interacting proteins
• FXR1P• FXR2P• CYFIP1 and CYFIP2• Poly(A)-binding protein• eIF2C2/AGO1 • Dicer • kinesin heavy chain
QuickTime™ and aYUV420 codec decompressor
are needed to see this picture.
Synaptic transmissionSynaptic transmission
FXS Un Dendritic Spine Structural Anomalies in Fragile-X Mental Retardation Syndrome
Irwin, Galvez and William T. Greenough
Cerebral Cortex (2000)
Results of “fishing” for FMRP interacting proteins
Results of “fishing” for FMRP interacting proteins
• FXR1P• FXR2P• CYFIP1 and CYFIP2• Poly(A)-binding protein• eIF2C2/AGO1 • Dicer • kinesin heavy chain
Take home messagesTake home messages
• FXTAS and FXPOI result from repeat-induced hyperexpression of the FMR1 gene and the deleterious effects of high levels of CGG-repeat containing mRNA.
• FXS results from repeat-induced gene silencing.• silencing leads to a deficiency of FMRP, a protein
important for the regulation of translation in the synapses of neurons
• the resultant abnormal expression of proteins like mGluR5, GSK-3, GABAA and MMP-9 results in the symptoms of FXS
• normalizing expression of these proteins may provide targeted approaches to the treatment of FXS.